Transaction in Own Shares and Total Voting Rights

Source: RNS
RNS Number : 6777M
Somero Enterprises Inc.
19 November 2024
 

Somero Enterprises, Inc.

("Somero" or the "Company")

 

Transaction in Own Shares

and Total Voting Rights

 

The Company announces that on 18th November 2024, it purchased ordinary shares of USD0.001 in the Company ("Ordinary Shares") to be cancelled in due course, pursuant to the share buy-back programme announced on 5 March 2024.

Date of purchase: 18th November 2024    

Number of Ordinary Shares purchased: 5,067

Highest price paid per Ordinary Share: 296 pence

Lowest price paid per Ordinary Share: 296 pence

Volume weighted average price paid per Ordinary Share: 296 pence

Following the above transactions and subsequent cancellation, the Company advises that its issued share capital is 54,908,160 Ordinary Shares. All of the shares have equal voting rights and there are no shares held in treasury and so the total voting rights of the Company are 54,908,160.

 

Enquiries:

 

 

 

 

Somero Enterprises, Inc.

Jack Cooney, President & CEO

Vincenzo LiCausi, CFO

Howard Hohmann, EVP Sales

 

www.somero.com

+1 239 210 6500

 

 

 



Cavendish Capital Markets Ltd (NOMAD and Broker)

Matt Goode/Seamus Fricker (Corporate Finance)
Tim Redfern/Harriet Ward (ECM)


+44 (0)20 7220 0500

 

 



Alma Strategic Communications (Financial PR Advisor)

David Ison

Rebecca Sanders-Hewett

Will Merison


somero@almastrategic.com

+44 (0)20 3405 0205

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSGPGACGUPCGQR